David is a software engineer by training. He founded the predecessor to Helix Health in 1987 and was the largest shareholder at the time of its sale in 2014. He was an early backer of Smiles Dental and sits on the board of a number of SMEs.
Matt was previously CFO of Helix Health and before that spent 8 years as a corporate finance adviser with Hawkpoint Partners in London. He led Causeway Capital’s investment in BB’s and sits on its board.
Pierce joined Causeway Capital Partners in 2017 having previously worked in corporate finance and investment banking in London, latterly as Vice President in Lincoln International. Pierce trained with KPMG in Dublin and is a Chartered Accountant.
Non Executive advisers
Gerard is a non-executive member of the Causeway Capital investment committee. He was previously Chairman of KPMG Corporate Finance Ireland and sits on a number of SME company boards.
Emmet is a non-executive member of the Causeway Capital investment committee. He founded Smiles Dental in 2005 and led the exit to Oasis Dental (backed by Bridgepoint) in 2014. He was most recently CEO of Topaz before its sale to Couche-Tard.